rolipram and luminol
rolipram has been researched along with luminol in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Boichot, E; Escofier, N; Germain, N; Lagente, V; Martins, MA; Silva, PM | 1 |
Al-Ayadhi, LY; Al-Tuwajri, AS | 1 |
Other Studies
2 other study(ies) available for rolipram and luminol
Article | Year |
---|---|
Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Animals; Bronchoalveolar Lavage Fluid; Bucladesine; Cell Count; Cyclic AMP; Dose-Response Relationship, Drug; Endotoxins; Free Radical Scavengers; Inflammation; Interleukin-10; Lipopolysaccharides; Luminescent Measurements; Luminol; Lung; Male; Neutrophils; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Salmeterol Xinafoate; Superoxide Dismutase; Theophylline; Tumor Necrosis Factor-alpha; Zymosan | 1999 |
The synergistic effect of adenosine A2A receptors agonist, type IV phosphodiestease inhibitor and ATP-sensitive K channels activation on free radicals production and aggregation of human polymorphoneuclear leukocytes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine; Adenosine A2 Receptor Agonists; Cell Aggregation; Cell Survival; Cromakalim; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Drug Synergism; Free Radicals; Humans; Luminescent Measurements; Luminol; Neutrophils; Phenethylamines; Phosphodiesterase Inhibitors; Potassium Channels, Inwardly Rectifying; Reactive Oxygen Species; Receptor, Adenosine A2A; Respiratory Burst; Rolipram; Tetradecanoylphorbol Acetate | 2004 |